Back
Mirum Pharmaceuticals Vs. Arcutis Biotherapeutics Industry Stock Comparison
Buy
74
MIRM
Mirum Pharmaceuticals
Last Price:
44.73
Seasonality Move:
41.89%
Sell
26
ARQT
Arcutis Biotherapeutics
Last Price:
10.13
Seasonality Move:
101.78%
Buy
74
Mirum Pharmaceuticals (MIRM)
is a Buy
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $44.73. The Score for MIRM is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- MIRM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
26
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy, Sell or Hold?
- The current Arcutis Biotherapeutics [ARQT] share price is $10.14. The Score for ARQT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- ARQT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $44.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIRM is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARQT Stock Price Chart
What is Arcutis Biotherapeutics's stock price today?
-
The Arcutis Biotherapeutics share price today is $10.14
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing slight selling pressure.
MIRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.1 | Buy |
| Relative Strength Index (14 RSI): | 61.5 | Buy |
| Chaikin Money Flow: | 241949 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.13 - 43.39) | Buy |
| Bollinger Bands (100): | (38.22 - 42.38) | Buy |
ARQT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 55.7 | Buy |
| Chaikin Money Flow: | -485931 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.53 - 10.27) | Buy |
| Bollinger Bands (100): | (8.99 - 10.49) | Buy |
MIRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.76 | Buy |
| 20-day SMA: | 41.79 | Buy |
| 50-day SMA: | 40.33 | Buy |
| 200-day SMA: | 33.6 | Buy |
| 8-day EMA: | 43.39 | Buy |
| 20-day EMA: | 42.23 | Buy |
| 50-day EMA: | 40.89 | Buy |
| 200-day EMA: | 35.66 | Buy |
ARQT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.97 | Buy |
| 20-day SMA: | 9.64 | Buy |
| 50-day SMA: | 9.59 | Buy |
| 200-day SMA: | 9.5 | Buy |
| 8-day EMA: | 10.03 | Buy |
| 20-day EMA: | 9.79 | Buy |
| 50-day EMA: | 9.65 | Buy |
| 200-day EMA: | 9.16 | Buy |
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.04 per share, and an increase next year of $0.85 per share.
Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.57 per share, and an increase next year of $0.41 per share.
Mirum Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arcutis Biotherapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||